when did glp-1 drugs become popular Drug Market: the rapid growth of the diabetes and obesity market GLP-1 Agonists Weight Loss Drugs

Learn what they contain, what the science actually says, and what truly supports people using GLP-1 medications.

Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director

Chronic diseases such as obesity and diabetes, cardiovascular and inflammatory bowel diseases (IBD) share common features in their pathology

Imagine a single therapy that targets both appetite regulation and glucose control, tirzepatide is turning that vision into reality

Why the caveats: Most human data is observational, not randomized controlled trials designed to prove prevents dementia. So far, we cannot definitively say GLP-1 RAs prevent Alzheimers

Beyond these metabolic benefits, accumulating evidence indicates that GLP-1RAs exert immunomodulatory effects, including suppression of pro-inflammatory cytokines, enhancement of regulatory T-cell function, and improvements in adipose tissue and gut-derived immune signaling